Researchers have investigated the heterogeneity of EGFR mutation-positive NSCLC tumor cells through the lens of clonal evolution, proposing that EGFR-TKI resistance is intricately linked to a high degree of intracellular heterogeneity. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.